這篇新聞正在等待 AI 完整中文翻譯。請先閱讀摘要與原文來源。
[待翻譯] Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner
[AI 翻譯暫時失敗,請人工確認] Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it the first company fro...
本文為 AI 輔助中文翻譯與整理,內容依據原文來源: SCMP